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Abstract
Background: The use of opioid medications as treatment for chronic non-cancer pain remains controversial. Little
information is currently available regarding healthcare providers’ attitudes and beliefs about this practice among
older adults. This study aimed to describe primary care providers’ experiences and attitudes towards, as well as
perceived barriers and facilitators to prescribing opioids as a treatment for chronic pain among older adults.
Methods: Six focus groups were conducted with a total of 23 physicians and three nurse practitioners from two
academically affiliated primary care practices and three community health centers located in New York City. Focus
groups were audiotape recorded and transcribed. The data were analyzed using directed content analysis; NVivo
software was used to assist in the quantification of identified themes.
Results: Most participants (96%) employed opioids as therapy for some of their older patients with chronic pain,
although not as first-line therapy. Providers cited multiple barriers, including fear of causing harm, the subjectivity
of pain, lack of education, problems converting between opioids, and stigma. New barriers included patient/family
member reluctance to try an opioid and concerns about opioid abuse by family members/caregivers. Studies
confirming treatment benefit, validated tools for assessing risk and/or dosing for comorbidities, improved
conversion methods, patient education, and peer support could facilitate opioid prescribing. Participants voiced
greater comfort using opioids in the setting of delivering palliative or hospice care versus care of patients with
chronic pain, and expressed substantial frustration managing chronic pain.
Conclusions: Providers perceive multiple barriers to prescribing opioids to older adults with chronic pain, and use
these medications cautiously. Establishing the long-term safety and efficacy of these medications, generating
improved prescribing methods, and implementing provider and patient educational interventions could help to
improve the management of chronic pain in later life.
Background
The use of opioid medications to treat chronic non-cancer
pain (hereafter referred to as chronic pain) in older
patients remains controversial [1-3]. Two recently pub-
lished guidelines for managing chronic pain [1,2] recom-
mend that clinicians consider opioid therapy for older
patients who continue to report moderate-to-severe pain
or experience pain-related functional impairment despite
non-opioid therapy. However, a recently published com-
parative safety study with 12,840 participants (mean age =
80 years) suggested that opioids (vs. nonselective and
selective nonsteroidal anti-inflammatory medications)
confer substantial risks when used to treat older adults
with non-cancer pain disorders [3].
Little information is available regarding healthcare pro-
viders’ attitudes and practices regarding the use of opioids
as a treatment for chronic pain in older adults. Provider
concerns have been identified in prior studies that did not
focus on older adults [4-10]. Concerns identified in these
studies included the potential for patient addiction, toler-
ance and physical dependence [4-10]; abuse, misuse or
diversion of opioid medications [4,5,9-12]; inadequate pro-
vider training [5,9,12-14]; patient harm from adverse
effects [4,6,7,12]; and regulatory sanctions [5-7,9,10].
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pharmacokinetics, as well as higher rates of comorbidity,
polypharmacy, and frailty [15,16] complicate the manage-
ment of pain in later life, and likely increase providers’
concerns about using this class of medications in older
patients. Lin et al. [5] surveyed practicing geriatricians and
internists to assess for possible provider differences in atti-
tudes regarding the use of opioids as a treatment for
patients with chronic pain. Geriatricians voiced far less
concern for addiction and more concern for the possibility
that patients’ pain was being under-treated relative to
internists [5]. Provider concerns about causing harm from
pharmacologic interventions such as opioid use may con-
tribute to the under-treatment of pain, which is a recog-
nized problem and is associated with advancing age [17].
The Declaration of Montreal, a document developed at
the 1st International Pain Summit in 2010, states that
“access to pain management by adequately trained health
care professionals is a fundamental human right” [18].
Health care providers therefore have an ethical responsi-
bility to relieve pain-related suffering by providing
informed and unbiased access to pain medications.
Identifying primary care providers’ barriers to the use
of opioids as a treatment for chronic pain among older
adults could identify possible targets for intervention,
and ultimately improve pain management in this
expanding patient population. Accordingly, we sought to
elucidate primary care providers’ perceived barriers and
facilitators to prescribing opioids as a treatment for
chronic pain among older adults. We also sought to
characterize providers’ experiences and attitudes towards
using this class of medications in older patients.
Methods
Design
This was a qualitative, cross-sectional study that employed
focus groups to generate discussions among health care
providers.
Study Sites
Focus groups were conducted at the Columbia Presbyter-
ian Allen Pavilion Division of Geriatrics and the New-
York-Presbyterian (NYP) Wright Center on Aging. These
sites serve predominantly older Latino and non-Hispanic
white patients, respectively. Both practices provide care
to patient populations that are older (mean age in the
mid 80s) and predominantly female and were selected
because they include providers with substantial experi-
ence caring for older adults. Many patients seen at the
practice have significant functional and/or cognitive
impairments. However, most patients live independently
in the community, while about 10% reside in assisted-liv-
ing facilities. Neither practice provides outpatient care to
residents of long-term care facilities. Physicians provide
longitudinal patient care, while the nurse practitioners
see “walk-ins,” but do not provide longitudinal care. To
increase the diversity of study sites, one focus group was
also conducted with providers from three community
health centers within the NYP Ambulatory Care Network
that serve predominantly Latino patients. In these three
practices, virtually all patients live independently in the
community. Because the health centers serve patients
across a broad range of ages, fewer patients have func-
tional or cognitive deficits relative to the geriatric care
practices described above. The study was approved by
the Weill Cornell Institutional Review Board.
Study Participants
All physicians and nurse practitioners (NP) providing
care in the above practices were eligible to participate,
i.e., no exclusion criteria were employed. Recruitment at
the Allen Pavilion and the Wright Center for volunteers
occurred during routine staff meetings. Participants
were recruited based upon their interest and availability
to attend one of the focus group sessions. Each partici-
pant selected a time that was convenient from the
groups offered. Medical directors at the three commu-
nity health centers were contacted to recruit providers
at these practices. Of 38 eligible providers at the five
practices, 26 (68%) participated in a focus group. Partici-
p a n t sa t t e n d e daf o c u sg r o u pt h a tw a sc o n v e n i e n tf o r
them. There was no attempt to ensure homogeneity of
participants (e.g., in terms of gender, age, years of clini-
cal experience) across the various groups. Of the 12 pro-
viders who did not participate, all cited scheduling
conflicts as a reason for not participating. Participants
did not differ from nonparticipants with respect to age,
gender, race/ethnicity status, or years of training.
Focus Group Methodology
One of two investigators (MCR or AS) introduced the
study, explained the focus group objectives and process
and then moderated a semi-structured discussion using
open-ended questions and follow-up probes that were
created based upon a review of the literature and pilot
tested prior to use in the current study. Providers were
asked to share their experiences using opioids in older
adults with chronic pain, characterize their use of these
medications, describe perceived barriers and facilitators
to prescribing opioids prescribing to their older patients,
voice any legal/regulatory or abuse/misuse concerns,
and finally describe their comfort level(s) prescribing
opioids for older patients with chronic pain and those
receiving palliative or hospice care. Demographic and
practice-relevant data were collected at the end of each
focus group via a self-administered questionnaire.
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All focus groups were audiotape recorded, transcribed,
and analyzed via directed content analysis [19]. The qua-
litative data were analyzed after each focus group. The
transcripts were read and then preliminary themes were
generated taking into consideration themes identified in
previous studies (e.g., barriers to opioid prescribing), as
well as newly identified themes. The basic unit of analysis
consisted of discrete sections of text that were felt to
convey an idea or construct by the investigators. For
example the phrase, “A lot of my patients don’tw a n tt o
take opioids, which is a big impediment to prescribing
them,” was coded as “patient reluctant to take opioid.”
Two investigators (AS, MCR) reviewed the focus group
data independently and then met to discuss observations
and reconcile divergent interpretations until agreeing
upon a single common set of themes. The transcripts
were again reviewed and the data from the common set
of themes were entered into QSR NVivo 8 [20] to facili-
tate theme sorting and counting. Focus groups were con-
ducted until the investigators agreed that the discussions
produced no new themes, i.e., thematic saturation was
reached.
Results
Focus Groups and Participants
Six provider focus groups were conducted, ranging in
size from three to eight participants and lasting from 35
to 60 minutes. Table 1 shows that providers (23 physi-
cians and 3 nurse practitioners) had a mean age of 40
years, were mostly female (77%), and reported an aver-
age of 12 years in practice.
Providers’ Opioid Prescribing Practices and Attitudes
Table 2 presents information on participants’ practices
and attitudes about prescribing opioids to older patients
with chronic pain. Twenty-five of the 26 participants
prescribed opioids as a treatment for chronic pain in at
least some of their older patients. Of these, all but one
indicated doing so cautiously. There was unanimous
a g r e e m e n tt h a to p i o i d sw e r enot first-line treatments.
Most providers used phrases such as ‘cautious’ or ‘hesi-
tant’ when describing their opioid prescribing practices
in older patients. Despite these concerns, a significant
minority (42%) related that opioids were effective when
used in the “right” older patient. As one participant
reported:
These medications work when given to the right
patient, those who can understand the regimen and
can anticipate the side effects. I have many people, one
of whom was here today, who are getting relief from it
and I think being able to live a life because of it.
Participants reported considering numerous patient
factors when deciding whether to prescribe an opioid.
Factors that increased the likelihood of prescribing
included a reliable patient, the presence of a reliable
caregiver in the home, an identifiable etiology of pain,
and a history of benefiting from opioids in the past
(Table 2). Conversely, providers stated they were far less
likely to initiate a trial of an opioid therapy if the provi-
der did not feel the patient was reliable, if the patient
did not have a reliable family member or caregiver in
the home, and when cognitive impairment, polyphar-
macy or impaired drug metabolism was present.
Provider Barriers to Opioid Use
Table 3 shows the various prescribing barriers and facili-
tators that participants endorsed and indicates which
ones have been previously reported.
Fear of causing harm
The most commonly reported barrier to initiating opioid
therapy (reported by 77% of participants) was a fear of
causing harm or that the potential harms outweighed
Table 1 Study Participants’ Characteristics
Characteristics Total
(N = 26)
Mean age, years (range) 40 (28-60)
Female, n (%) 20 (77)
Non-Hispanic white, n (%) 14 (54)
Provider type, n (%)*
Physician 23 (88)
Nurse practitioner 3 (12)
Physicians (n = 23) with geriatric fellowship training, n
(%)
21 (91)
Mean number of years in practice, n (range) 12 (4-39)
More than 50% of time in direct patient care, n (%) 22 (87)
More than 75% of patients above age 65, n (%)
† 20 (77)
Residence status of practice patients, (%)
Independent (90)
Assisted-living (10)
Percentage of older patients with chronic pain, n (%)
†
<25% 10 (38)
26-50% 9 (35)
51-75% 5 (19)
>75% 1 (4)
Percentage of older patients with chronic pain on an
opioid, n (%)
†
0-5% 5 (20)
6-15% 13 (52)
16-25% 6 (24)
>25% 1 (4)
* Physicians provide longitudinal care in the 3 study practices, while nurse
practitioners see ‘walk ins’ and cover for physicians, but do not provide
longitudinal care.
†N = 25 for these items.
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described:
Ij u s th a v eah a r dt i m ep r e s c r i b i n go p i o i d si nm y
older patients. I get frightened with 80+ year olds;
how are they going to respond? Am I going to abso-
lutely drop them to the floor even with a small
dose?
Fear of causing harm was often related to previous
clinical experiences:
One of my 96 year-old female patients got an opioid
and went to sleep for three days after taking it. It
really clouded her sensorium, so that was a negative
experience for her as well as for me.
Related to the fear of causing harm was the guilt some
physicians experienced (or might experience) on account
of opioid-related adverse events, causing them to think
carefully before prescribing an opioid:
If something does happen to them, you feel guilty and
want to crawl under a table when they’re in the emer-
gency room and you get the call that they fell while on
the fentanyl patch you gave them. That kind of experi-
ence is powerful and definitely factors into the
equation.
Table 2 Attitudes and practices regarding opioid prescribing in older adults
Participants mentioning (N = 26) n (%)
Attitudes and practices
Does not consider opioid to be first-line treatment 26 (100)
Prescribes to older adults as treatment for chronic pain 25 (96)
Uses cautiously or hesitantly 24 (92)
Endorses greater comfort prescribing to palliative care patients 19 (73)
Viewed as effective therapy for certain older patients 11 (42)
Factors that increase likelihood of prescribing
Reliable patient and reliable caregiver in the home 12 (46)
Identifiable etiology of pain 8 (31)
History of beneficial results with opioid use in the past 5 (19)
Factors that decrease likelihood of prescribing
Patient is unreliable or no caregiver in the home 13 (50)
Cognitive impairment 8 (31)
Polypharmacy or impaired drug metabolism 4 (15)
Table 3 Specific Barriers and Facilitators to Opioid Prescribing in Older Adults
Themes Participants mentioning
(N = 26) n (%)
Newly identified theme
*
Provider-level barriers
Fear of causing harm from adverse effects 20 (77) No
4,6,7,12
Subjectivity of pain 16 (62) No
11,24
Lack of education in pain management 9 (35) No
5,9,12-14
Problem converting or dosing opioids 8 (31) No
5
Concern for abuse, addiction or dependence 5 (19) No
4-12
Concern for legal/regulatory sanction 3 (12) No
5-7,9,10
Concern for family member/caregiver abuse 3 (12) Yes
Patient/family-level barriers
Older patients reluctant to take opioid 18 (69) Yes
Stigma 15 (58) No
6
Family reluctant to have older patient take opioid 10 (38) Yes
Financial (medication costs) 6 (23) No
6
Facilitators
Patient and family education about opioids 14 (54) Yes
Studies demonstrating long-term benefit and validated risk assessment tools 11 (42) No
12
Easy access to peer or specialist support 7 (27) Yes
Evidence-based tools to help calculate starting dose 3 (12) Yes
*Studies focused on barriers in adult populations with chronic pain (not older adult populations).
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Another frequently cited barrier (by 62%) was the sub-
jectivity of patients’ pain reports, which was often asso-
ciated with an inability to establish an organic cause of
pain. Providers remarked that the subjective complaint
of pain was sometimes a manifestation of some psycho-
social problem:
I have a lot of patients who come in and always have
pain, and there is no physical reason for it; I think
much of it is psychological.
Other providers remarked that patients’ pain com-
plaints/pain scores often did not correspond with
their behavior during the visit, which contributed to
provider skepticism about the amount of pain
patients were experiencing and reluctance to pre-
scribe opioids:
[I have patients who report that] their back hurts all
the time, but then they jump right up onto the exam
table, I don’t get that.
Or as another physician recounted:
If I were in 10 out of 10 pain, I would be crying. I
would be either in a fetal position, unable to make
noise or crying hysterically and screaming. To me, 10
o u to f1 0i st h ew o r s tp a i nIc o u l di m a g i n e .A n ds o
it’s really hard not to judge your patient who tells
you, “Oh my pain’s 10 out of 10 for sure, but the first
thing I want to talk to you about is the fungus on my
toenails because they’re ugly.”
Concerns about regulatory and/or legal sanctions
Of the 23 physician participants, only 9% reported con-
cerns about possible legal or regulatory sanctions as a con-
sequence of prescribing opioids as treatment for chronic
pain. However, all three nurse practitioners voiced sub-
stantial apprehension about possible sanctions because of
writing a high volume of prescriptions, often refilling pre-
scriptions on days the patient’s physician was not present
in the practice.
Concerns about opioid abuse, misuse or addiction
Only one participant voiced concerns about the possibility
of older patients abusing opioids, while four shared con-
cerns about older patients using the medication to treat
non-pain symptoms or conditions (e.g., using the medica-
tion as a sleep aid), a type of medication use that all four
providers characterized as opioid misuse. Three partici-
pants relayed concerns about abuse/misuse, not by
patients but by their caregivers (e.g. home attendants or
family members).
Eight providers reported either low (or no) concern
for addiction or dependence in older adults. As one
stated:
I have a patient who continues to complain about
her pain. She doesn’t even want to take Tylenol #3.
S h ei si nh e r8 0 sa n ds a y s ,“No narcotics! No, no,
no! Don’tg i v em ea n y t h i n gl i k et h a t ! ” Iw o u l dl o v e
to give her something, but [to the patient] an addic-
tion is an addiction. I mean she’s 80-something, how
addicted is she going to get?
One physician with low concern for addiction also
emphasized that pain control is imperative to improving
quality of life in later years and that he counseled
patients saying:
Chronic pain restricts social activity and your activ-
ity choice. If pain is not as severe, you are better
able to do things you want to do.
Facilitators to Opioid Use
Table 3 also shows the factors that providers stated
would make them more likely to prescribe an opioid to
an older patient with chronic pain: Patient and caregiver
educational interventions; well-conducted studies that
demonstrate benefit, validated tools to identify high risk
older patients and evidence-based methods to help cal-
culate appropriate starting doses for older patients with
comorbidities; as well as peer support, i.e., the ability to
quickly consult a colleague possessing pain management
expertise.
Perceived Patient-Level Barriers to Opioid Use
A majority of providers (69%) reported that many older
patients were very reluctant to take opioids because of
multiple concerns, includin gb o t h e r s o m es i d ee f f e c t s ,
concerns about costs, and worries about addiction. Sev-
eral providers felt that patients’ reluctance to try an
opioid medication acted as a barrier to prescribing this
class of medication to future patients:
It’s [the side effects] in addition to their knowledge
that these meds are addictive. That might make it so
that even when we get over our barriers to giving
them, there are barriers on the patient side, and that
reinforces [the notion that] they don’tw a n ti ta n y -
way. So, I’m not going to bother offering it to the
next patient [who presents with significant pain].
Twelve percent of participants also reported that older
patients’ family members functioned as a barrier at
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patient take an opioid. More than half (58%) reported
that “stigma” was a barrier, causing many patients to
avoid opioid therapy altogether. As one physician work-
ing in a community health center noted:
Patients hear the word codeine or some [other
opioid] that they recognize and they think of it as a
street drug, and don’tw a n tt ob ea s s o c i a t e dw i t h
that. I think in this population, when street crime is
so rampant, and they have families who have been
hurt by street crime or family members who are in
jail because of selling, patients are very hesitant.
Stigma could also lead patients to stop taking an opioid
medication altogether. Another physician relayed that:
Patients have told me, they’re respectable people
mind you, that they would go into the pharmacy
and [the pharmacist] would yell out “we don’th a v e
any methadone” in front of all the people waiting in
the pharmacy.
Differences in Identified Themes Across the Practices
An analysis of the themes by practice site revealed that
stigma was the only theme to be more frequently
endorsed by providers in practices serving Hispanic
patients. All remaining themes were equally endorsed
across the 5 practice sites.
Other Themes
Greater comfort using opioids in patients receiving
palliative care
Seventy three percent of the sample stated that they
were much more comfortable prescribing opioids to
patients receiving palliative or hospice care, as compared
to patients receiving treatment for chronic pain. Reasons
included the indefinite period of treatment (for patients
with chronic pain), divergent goals of care (i.e., comfort
versus pain control with maintenance of function) and a
different perceived risk-benefit ratio for the two groups.
As one physician confided:
It might be that you are treating for a limited
amount of time, just like acute pain, you’re just get-
ting them through the last few weeks, months, or
f e wy e a r s . . .s om a y b ew ef e e lm o r ec o m f o r t a b l e
[treating palliative care patients with opioids],
whereas the patient with chronic back pain you
don’th o wl o n gy o u ’re going to be treating him or
her, the patient can be 60 and treated for 35 years
with narcotics, so yes, I think it’s a risk-benefit issue.
Frustration treating pain in primary care
While not related directly to opioid use in older adults,
a theme of frustration treating patients with pain was
identified. As one of the 8 physicians who endorsed this
theme described:
Treating pain is one of the most frustrating things
we do, there’s a lot of pressure to treat pain, I mean
we do the pain scale, we’re mandated to do the pain
scale, every time I go to a continuing medical educa-
tion class, they’re always telling me how little we
treat pain, but the problem is, we don’tk n o wh o w
to treat pain. And so everybody is telling me I’m not
treating pain well, but nobody is helping me figure
out how to treat the pain.
Discussion
This investigation focused on primary care providers atti-
tudes’ and practices regarding opioid use as a treatment
for chronic pain in older adults. Our study extends
research in this area by documenting new prescribing
barriers and facilitators, and highlights interventions that
could, if implemented, possibly improve appropriate use
of opioid therapy. First, older patient and family reluc-
tance to try an opioid medication was perceived to be a
major barrier. Many physicians described cases where
they were unable to overcome patients’ reluctance to try
an opioid medication, whereas others recounted having
patients in substantial pain who took the prescription,
but would not fill it. Furthermore, almost 40% of provi-
ders reported that they had encountered resistance from
a family member/caregiver when attempting to prescribe
an opioid medication. Over half of all participants felt
that interventions that educated patients and family
members about the benefits and risks of opioid analgesic
(relative to other classes of analgesic medications) could
facilitate use of opioids in this age group. Establishing the
long-term risks and benefits of therapy and generating
validated tools to estimate risk for adverse outcomes
were also judged to be important facilitators of future
opioid use.
This study is also the first to document that opioid
abuse/misuse by family members or caregivers constitu-
tes a potential prescribing barrier. This concern was
endorsed by 12% of providers. According to a recent
study [21] friends, family and elderly are a significant
source of opioid diversion. Older people may be at
greater risk for diversion because of declining cognition,
dependence on caregivers and economic hardship, mak-
ing this an important issue for providers to be aware of
when prescribing opioids to older patients. These find-
ings, coupled with prior research showing that older
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locations [22] and that opioid use is increasing nation-
ally [23] supports future efforts to determine whether
and to what extent older adults constitute an important
route for opioid diversion.
Our study suggests that the primary barrier to pre-
scribing opioid analgesics among older adults with
chronic pain is a fear of causing harm. A recently pub-
lished guideline for managing chronic pain in older
adults [1] encourages clinicians to consider using opioid
therapy, but acknowledges that this recommendation is
based on medium- to low-quality evidence. Indeed, a
recent observational study that examined analgesic-
related risks in an exclusively older population of
patients [3] found that participants who were prescribed
opioids had a significantly increased risk of fracture,
hospitalizations, and all-cause mortality compared to
those prescribed non-selective non-steroidal-anti-inflam-
matory drugs (NSAIDs) or selective NSAIDs. This study
had limitations, including an inability to account for
actual consumption of prescribed medications and con-
current use of over-the-counter analgesics. In addition,
clinical experience suggests that opioid therapy is typi-
cally the last pharmacotherapy to be tried, so it stands
to reason that patients who received opioids were sicker
at baseline with more functional impairment. Overcom-
ing the ‘fear of causing harm’ barrier will likely require
studies that confirm the long-term efficacy of this class
of medications and practical strategies for minimizing
attendant risk.
Prior investigations [11,24] suggest that pain subjectiv-
ity constitutes a strong barrier to opioid prescribing; this
finding was confirmed in the current study. Many provi-
ders doubted patients reports of pain, as illustrated in
statements such as “there is no physical reason for it; I
t h i n km u c ho fi ti sp s y c h o l o g i c a l . ” This suggests incom-
plete provider understanding of the etiology of chronic
pain and inadequate trainingi nw h a ti sk n o w na b o u ti t s
clinical presentation. One study [11] demonstrated that
physicians who believe that chronic pain always has a
physical cause were more likely to report prescribing
opioids for chronic pain. However, with chronic pain
there is often no identifiable organic cause [25,26], which
contributes to uncertainty around whether and how best
to intervene. These findings support future educational
interventions that seek to improve provider training in
assessing and managing chronic pain.
Our results also differ from prior related studies in
several important ways. First, prior investigations [4-14],
which focused on attitudes and barriers to opioid pre-
scribing in adult (but not exclusively older adult) popu-
lations, found that provider concerns about opioid abuse
and addiction constituted a major prescribing barrier. In
the current study, few providers voiced this concern.
One possible explanation for this difference is an age
cohort effect. Indeed, prior research [27-30] has docu-
mented that advancing age is associated with signifi-
cantly decreased risk for abuse/misuse of opioid
medications. In addition, concerns about legal/regulatory
sanctions constitute a frequently reported barrier to
opioid prescribing [5-7,9,10], but were infrequently
endorsed in the current study. This discrepancy may be
explained by a lower prevalence of opioid analgesic pre-
scribing in the study practices (relative to other study
sites) or that the likelihood of administrative sanction by
a state board is perceived to be lower in New York rela-
tive to other states.
Managing older patients with chronic pain is frequently
a complex and challenging task, which is often com-
pounded by feelings of helplessness and an inability to
optimally manage pain on the part of healthcare provi-
ders [31,32]. Many providers in this study expressed sig-
nificant frustration treating patients with chronic pain.
This theme was endorsed by participants with relatively
few years of clinical experience, as well as from those
with many years of experience. Providers attributed their
frustration to the previously mentioned barriers, particu-
larly the subjectivity of pain, along with the pressure of
mandates to assess and treat pain. Mandates and guide-
lines put in place to improve pain management among
older adults will likely continue to contribute to frustra-
tion if the barriers that providers experience are not suc-
cessfully addressed.
What types of research/initiatives could help to address
the frustration that a significant minority of providers
endorsed regarding managing patients with chronic pain?
Providers viewed future studies that ascertain the long-
term safety and efficacy of these drugs and how different
subgroups of older patients respond to varying opioid
medication regimens to be particularly relevant. These
data could be used to develop evidence-based guidelines
and algorithms for opioid prescribing in later life. Such
data, along with improved training [32], may instill in
providers a greater sense of confidence when prescribing
opioids to older adults. This could also help providers
when counseling patients and caregivers about opioid
medications, which could serve to address the barrier of
patient or caregiver reluctance.
Our results also provide support for future efforts to
improve provider training and access to peer support.
Preliminary testing of a clinical decision support system
to facilitate opioid prescribing for chronic pain in pri-
mary care is encouraging [33]. Additionally, a recent
study [34] evaluated a tool to identify older patients at
risk for adverse drug events, which may support develop-
ment of a tool to assess risk associated with opioid use.
Tools such as these may help to overcome some of the
barriers identified in this and prior investigations
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dosage calculations, and peer support, and help to sup-
port appropriate documentation in the medical record
and decrease provider frustration. Finally, it is important
to acknowledge that providers, patients, and caregivers
can have very different tolerance levels for risk regarding
the use of medications for the treatment of pain. Gener-
ating efficient ways to solicit patients’ and/or caregivers’
risk levels and to have providers’ acknowledge their
respective concerns about level of risk these medications
entail -prior to arriving at a joint decision about initiating
a course of opioid therapy -should also be a focus of
future work.
There are several limitations to this study. Although all
participants engaged in the focus group discussions,
because of group dynamics and the participants’ relation-
ship as colleagues, these data may not have accurately
captured the full extent of participants’ views on this
topic. Additionally, the actual prescribing patterns and
clinical impact of the perceived barriers are unknown.
We did not formally calculate an index of inter-coder
agreement when analyzing our qualitative results. How-
ever, disagreement between raters occurred rarely when
coding the themes reported in this paper, indicating that
overall inter-rater agreement was high. The sample was
small, non-random, and limited to providers at two aca-
demically affiliated and three community-based primary
care practices in New York City. Finally, most providers
cared for predominantly older adults of White or Hispa-
nic origin. Our findings may not generalize to other race/
ethnicity groups or non-elderly populations.
Conclusions
In conclusion, this study demonstrated that primary care
providers perceive multiple barriers to the use of opioids
for older adults with chronic pain and use opioids cau-
tiously for this purpose. Newly identified barriers include
older patient/family member reluctance to take an opioid
and the possibility of opioid abuse by caregiver (e.g.,
family members and home attendants). Further work
directed at addressing the identified barriers and optimal
ways to facilitate decision making when tolerance levels
for risk vary between providers and patients/caregivers
will be needed.
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